Alzheimer's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Alzheimer's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape.

Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the synthesis of neurotransmitter acetylcholine which is further responsible for the transmission of signals. Predisposing factors include age, heredity, cardiovascular diseases or diabetes and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability and aggressiveness.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alzheimer's Disease - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Alzheimer's Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alzheimer's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alzheimer's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 24, 76, 100, 1, 9, 387, 203 and 8 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 3, 2, 109 and 52 molecules, respectively.

Alzheimer's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Alzheimer's Disease (Central Nervous System).
• The pipeline guide reviews pipeline therapeutics for Alzheimer's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Alzheimer's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Alzheimer's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Alzheimer's Disease (Central Nervous System)

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Alzheimer's Disease (Central Nervous System).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Alzheimer's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies Mentioned
Companies Mentioned

1st Bio Therapeutics Inc
2A Pharma AB
4B Technologies (Suzhou) Co Ltd
4P-Pharma SAS
AB Science SA
Abaxy Sprl
AbbVie Inc
Abrexa Pharmaceuticals Inc
Abyssinia Biologics LLC
AC Immune SA
Acadia Pharmaceuticals Inc
Accuitis Pharmaceuticals Inc
Acelot Inc
Actinogen Medical Ltd
Acumen Pharmaceuticals Inc
Addex Therapeutics Ltd
ADEL Inc
Adocia SAS
ADRx Inc
Aerobyx LLC
Aeton Therapeutics Inc
AevisBio Inc
AfaSci Inc
AIBIOS Co Ltd
Ailon Co Ltd
Akome Biotech Ltd
Alchemab Therapeutics Ltd
Alector Inc
Alfasigma SpA
Alkahest Inc
Alkermes Plc
Allyx Therapeutics Inc
Alnylam Pharmaceuticals Inc
Alopexx Inc
AlphaCognition Inc
Alsonex Pty Ltd
ALSP Inc
AltPep Corp
Alzamend Neuro Inc
AlzeCure Pharma AB
Alzheon Inc
Alzhyme Pty Ltd
Alzinova AB
AlzProtect SAS
Amyloid Solution Inc
Amylon LLC
Amylyx Pharmaceuticals Inc
AmyriAD Therapeutics BV
Anavex Life Sciences Corp
Anhorn Medicines Co Ltd
Anima Biotech Inc
Ankar Pharma SL
ANLBio Co Ltd
Annovis Bio Inc
Antoxerene Inc
Anven AlzDx Inc
Aphios Corp
Apollo Therapeutics LLC
Applied Research using OMIC Sciences SL
Aprinoia Therapeutics Inc
AptaBio Therapeutics Inc
Aquinnah Pharmaceuticals Inc
Araclon Biotech SL
Archer Pharmaceuticals Inc
AriBio
ArmaGen Inc
ARMGO Pharma Inc
Artery Therapeutics Inc
Arvinas Inc
Asceneuron SA
Asdera LLC
Ashvattha Therapeutics LLC
Asklepios BioPharmaceutical Inc
Astellas Pharma Inc
AstraZeneca Plc
Astrocyte Pharmaceuticals Inc
Astrogen Ltd
AstronauTx Ltd
Atalanta Therapeutics Inc
Athira Pharma Inc
ATP Biopharm
Atux Iskay Group LLC
Augustus BioTarget Inc
Auransa Inc
Aurin Biotech Inc
Autifony Therapeutics Ltd
Autophagy Neurotherapeutics Inc
Autotac Bio Inc
Avanti Biosciences Inc
Avidin Biotechnology Ltd
Avineuro Pharmaceuticals Inc
Axoltis Pharma SAS
Axon Neuroscience SE
Axxam SpA
AZTherapies Inc
Beijing Joekai Biotechnology LLC
Berg LLC
BeyondBio Inc
Bio-Pharm Solutions Co Ltd
BioArctic AB
Biogen Inc
Biohaven Pharmaceutical Holding Company Ltd
Biom Therapeutics LLC
Biorchestra Co Ltd
Biosplice Therapeutics Inc
BioVie Inc
BioXcel Therapeutics Inc
Bisichem Co Ltd
Boehringer Ingelheim International GmbH
Bolden Therapeutics Inc
Bolder Biotechnology Inc
Boryung Pharmaceutical Co Ltd
Brain Innovation Co Ltd
BrainStorm Cell Therapeutics Inc
Brainvectis SAS
Bright Minds Biosciences Inc
Buto Corp
C4 Therapeutics Inc
C4X Discovery Holdings Plc
Cantabio Pharmaceuticals Inc
Caren Pharmaceuticals Inc
Carna Biosciences Inc
CaSRevolution SRL
Cassava Sciences Inc
CavoGene LifeSciences
CellCure
CellTex Therapeutics Corp
Cenna Biosciences Inc
Cennerv Pharma (S) Pte Ltd
Center Laboratories Inc
CerebraMed
Cerecin Pte Ltd
Cerevance Inc
Cesa Alliance SA
CHA Biotech Co Ltd
Changchun Huayang High-Tech Co Ltd
Chaperone Therapeutics Inc
Chengdu Jinrui Foundation Biotechnology Co Ltd
Chengdu Kanghong Pharmaceuticals Group Co Ltd
Chimerna Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Circadian Therapeutics
Circumvent Pharmaceuticals Inc
Clayton Biotechnologies Inc
Clene Inc
Clevexel Pharma SA
CMG Pharmaceutical Co Ltd
Cogentis Therapeutics Inc
Cognition Therapeutics Inc
Cognosci Inc
CohBar Inc
Collaborations Pharmaceuticals Inc
Collaborative Medicinal Development LLC
CoPlex Therapeutics LLC
Corium Inc
Cortexyme Inc
Cortice Biosciences Inc
Covalent Bioscience Inc
Coya Therapeutics Inc
Creative Bio-Peptides Inc
Crossbeta Biosciences BV
CuraSen Therapeutics Inc
Cure Network Dolby Acceleration Partners LLC
CuroNZ Ltd
Cyclerion Therapeutics Inc
Cyclica Inc
Cyclo Therapeutics Inc
CycloLab Cyclodextrin Research and Development Laboratory Ltd
Cytonus Therapeutics Inc
Dadang & BIO Co Ltd
Daewoong Pharmaceutical Co Ltd
DanDi Bioscience Inc
DanPET AB
DegenRx BV
Denali Therapeutics Inc
Denovo Biopharma LLC
Diffusion Pharmaceuticals Inc
Dong Wha Pharma Co Ltd
Dong-A ST Co Ltd
DongKoo Bio & Pharma Co Ltd
Dongkook Pharmaceutical Co Ltd
E-scape Bio Inc
Eagle Pharmaceuticals Inc
EastGate Pharmaceuticals Inc
Eikonizo Therapeutics Inc
EIP Pharma LLC
Eisai Co Ltd
Eleusis Ltd
Eli Lilly and Co
Elixirgen Therapeutics Inc
Elixiron Immunotherapeutics Inc
Emerald Organic Products Inc
EmphyCorp Inc
Empriver LLC
Endece LLC
Enterin Inc
Entrada Therapeutics Inc
Epigen Biosciences Inc
Epitracker Inc
Epsilon Molecular Engineering Inc
EuMentis Therapeutics Inc
Everfront Biotech Inc
Evero Health Ltd
Expesicor Inc
Exscientia Plc
F. Hoffmann-La Roche Ltd
Foresee Pharmaceuticals Co Ltd
Forest Hills Partners Hong Kong Ltd
Fortuna Fix Inc
Fox Chase Chemical Diversity Center Inc
FUJIFILM Toyama Chemical Co Ltd
G2GBIO Inc
GABA Therapeutics Inc
Gabaeron Inc
Gabather AB
Galimedix Therapeutics Ltd
GAOMA Therapeutics
GemVax & KAEL Co Ltd
Gene Therapy Research Institution Co Ltd
GeneLeap Biotech
Genentech USA Inc
Genervon Biopharmaceuticals LLC
GeneScience Pharmaceuticals Co Ltd
Genetic Intelligence Inc
Genuv Inc
Gismo Therapeutics Inc
GliaCure Inc
GliaPharm SA
Glycadia Inc
GNT Pharma Co Ltd
Golden Biotechnology Corp
Good T Cells Inc
GraySpace Therapeutics Inc
Grespo AB
Grifols SA
Guangzhou Dazhou Biomedical Technology Co Ltd
Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd
H. Lundbeck AS
Halia Therapeutics Inc
HEC Pharma Co Ltd
Herophilus
Holy Stone Healthcare Co Ltd
Hopstem Biotechnology LLC
Hoth Therapeutics Inc
Hyundai Pharma Co Ltd
ICB International Inc
Ildong Pharmaceutical Co Ltd
Imago Pharmaceuticals Inc
Immune System Key Ltd
Immuneering Corp
Immungenetics AG
ImmunoBrain Checkpoint Inc
ImmunoChem Therapeutics LLC
Immunwork Inc
Imnewrun Bioscience Co Ltd
Inmune Bio Inc
InnoBioscience LLC
Innosense LLC
Innovimmune Biotherapeutics Inc
Instituto Biomar SA
IntelGenx Corp
Interprotein Corp
Intra-Cellular Therapies Inc
IntraBio Ltd
INVENT Pharmaceuticals Inc
Invisio Ltd
Io Therapeutics Inc
Ionis Pharmaceuticals Inc
ISU ABXIS Co Ltd
Jace Biomedical Inc
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Kangyuan Pharmaceutical Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Johnson & Johnson
Jupiter Neurosciences Inc
Kalgene Pharmaceuticals Inc
Karuna Therapeutics Inc
KeifeRx LLC
Keystone Bio Inc
Kine Sciences
KinoPharma Inc
Klogene Therapeutics Inc
Kogenix Therapeutics Inc
Korea Pharma Co Ltd
Kwang Dong Pharmaceutical Co Ltd
Kyowa Kirin Co Ltd
Landos Biopharma Inc
Lauren Sciences LLC
Lead Discovery Center GmbH
Lennham Pharmaceuticals Inc
LEXEO Therapeutics LLC
Libella Gene Therapeutics
Light Chain Bioscience
Longeveron Inc
LSL Neurosciences LLC
Luye Pharma Group Ltd
Lyndra Therapeutics Inc.
Magnolia Neurosciences Corp
ManRos Therapeutics
MapLight therapeutics Inc
Marvel Biotechnology Inc
MaxiVAX SA
MD Healthcare Inc
MDimune Inc
MedBiome Inc
Medesis Pharma SA
Medifron DBT Co Ltd
medilabo RFP Inc
MEDRx Co Ltd
MegaNano BioTech Inc
MEI Pharma Inc
Mercia Pharma Inc
Merck & Co Inc
MetiMedi Pharmaceuticals Co Ltd
MetrioPharm AG
MetVital Inc
MGC Pharmaceuticals Ltd
Mindset Pharma Inc
Mission Therapeutics Ltd
Mitoconix Bio Ltd
Montisera Ltd
MYND Life Sciences Inc
NAL Pharmaceuticals Ltd
Nanomerics Ltd
NatureWise Biotech & Medicals Corp
Neonc Technologies Inc
NeoNeuro SAS
NeoProgen Inc
NervGen Pharma Corp
NeuExcell Therapeutics Inc
Neuracle Genetics Inc
Neuracle Science Co Ltd
Neuraly Inc
Neuramedy Co Ltd
Neurano Bioscience
Neurim Pharmaceuticals Ltd
Neurimmune Holding AG
Neuro Bio Ltd
Neuro-Sys SAS
NeuroActiva Inc
Neurocrine Biosciences Inc
Neurodegeneration Therapeutics Inc
Neurodon LLC
NeuroGeneration Inc
NeuroGenesis Ltd
NeuroGenetic Pharmaceuticals Inc
Neurokine Therapeutics
NeuroLucent Inc
Neuromagen Pharma Ltd
NeuroNascent Inc
NeurOp Inc
Neuropore Therapies Inc
NeuroScientific Biopharmaceuticals Ltd
NeuroSense Therapeutics Ltd
NeuroSolis Inc
NeuroTau Inc
Neurotez Inc
NeuroTherpia Inc
NeuTherapeutics Inc
Neuvivo Inc
New World Laboratories Inc
NewAmsterdam Pharma BV
Nexel Co Ltd
Nippon Chemiphar Co Ltd
NKGen Biotech Inc
NoNO Inc
Novartis AG
NovMetaPharma Co Ltd
Novoron Bioscience Inc
Nymox Pharmaceutical Corp
Olatec Therapeutics LLC
Oleolive LLC
Oligomerix inc
OncoSynergy Inc
Ono Pharmaceutical Co Ltd
Orpheris Inc
Orphi Therapeutics Inc
Oryzon Genomics SA
OTR3 SAS
Overseas Pharmaceuticals Ltd
Oxstem Ltd
P2D Inc
Palisade Bio, Inc
Panorama Researchama Research
Paramag Biosciences
Park of Active Molecules
Paros Bio Inc
Partner Therapeutics Inc
Passage Bio Inc
Peptron Inc
Perha Pharmaceuticals SAS
Peter Biotherapeutics Inc
Pharmasum Therapeutics AS
PharmatrophiX Inc
Pharmazz Inc
PharmCADD Co Ltd
Pharnext SA
Phoenix Biotechnology Inc
Phoenix Life Sciences International Ltd
Pinteon Therapeutics Inc
Plico Biotech Inc
Polaryx Therapeutics Inc
PolyCore Therapeutics LLC
Praetego Inc
Praxis Biotech LLC
Prevacus Inc
PRG S&Tech Inc
Priavoid GmbH
Prilenia Therapeutics Development Ltd
Proclara Biosciences Inc
Progenra Inc
ProMIS Neurosciences Inc
Protekt Therapeutics Ltd
Prothena Corp Plc
Protheragen Inc
Prous Institute for Biomedical Research SA
Provaidya LLC
Provention Bio Inc
Psy Therapeutics Inc
PurMinds NeuroPharma Inc
Qingdao Primedicine Pharmaceutical Technology Co Ltd
Quimatryx SL
RAGE Biotech Pty Ltd
Reata Pharmaceuticals Inc
Regenacy Pharmaceuticals LLC
Regenera Pharma Ltd
reMYND NV
ReNeuron Group Plc
Resilio Therapeutics LLC
ResQ Biotech
Retrotope Inc
Revalesio Corp
Reven Holdings Inc
Reviva Pharmaceuticals Inc
Revivo Therapeutics Inc
Riserx LLC
Rodos BioTarget GmbH
Rznomics Inc
Sage Therapeutics Inc
Saillant Therapeutics BV
Samjin Pharm Co Ltd
Samus Therapeutics Inc
SanBio Co Ltd
Sanofi
Scientus Pharma Inc
Seelos Therapeutics, Inc.
Selonterra Inc
Sentinel Oncology Ltd
Serometrix LLC
Shanghai Angecon Biotechnology Co Ltd
Shanghai Green Valley Pharmaceutical Co Ltd
Shanghai Rixin Biological Co Ltd
Shanghai SIMR Biotech Co Ltd
Shape Therapeutics Inc
Shaperon Inc
Shenzhen Salubris Pharmaceuticals Co Ltd
Simcere Pharmaceutical Group Ltd
SinoMab Bioscience Ltd
Siragen Pharmaceuticals Inc
Sironax Ltd
Smart Biomolecules Inc
SOLA Biosciences LLC
Sosei Group Corp
SparkBioPharma Inc
Spherium Biomed SL
Spinogenix Inc
Starwise Therapeutics LLC
Stellate Therapeutics Inc
Stream Biomedical Inc
Sun Pharma Advanced Research Company Ltd
Sunovion Pharmaceuticals Inc
Suntec Medical (Taiwan) Inc
Suven Life Sciences Ltd
Synapss Therapeutics Inc
SynapTEX LLC
Synaptogenix Inc
T3D Therapeutics Inc
Taho Pharmaceuticals Ltd
TaiMed Biologics Inc
Takeda Pharmaceutical Co Ltd
Talem Therapeutics Inc
TauC3 Biologics Ltd
TauRx Therapeutics Ltd
Techfields Pharma Co Ltd
TechnoPhage SA
Teikoku Pharma USA Inc
Teitur Trophics ApS
Telocyte LLC
Tetra Therapeutics
Tetraneuron SL
Teva Pharmaceutical Industries Ltd
The Greater Cannabis Company Inc
The National Institute for Biotechnology in the Negev Ltd
Thera Neuropharma Inc
Therini Bio Inc
Tiaki Therapeutics Inc
Time Therapeutics Inc
Tiziana Life Sciences Plc
Tonix Pharmaceuticals Holding Corp
Tranquis Therapeutics Inc
Transposon Therapeutics Inc
Treeway BV
Treventis Corp
Triplet Therapeutics Inc
TrueBinding Inc
UCB SA
Uni-Bio Science Group Ltd
UniQure NV
Unity Biotechnology Inc
USA Elixiria Biotech Inc
Vaccinex Inc
Vandria SA
Vanqua Bio Inc
Vanworld Pharmaceutical (Rugao) Company Ltd
Varinel Inc
Vaxxinity Inc
VectorY Therapeutics Inc
Ventus Therapeutics Inc
VFP Therapies
Videns Incorp Ltd
Vigil Neuroscience Inc
Virogenics Inc
Virpax Pharmaceuticals Inc
Vitro Diagnostics Inc
Vitruvian Biomedical Inc
Vivoryon Therapeutics NV
Vivreon Biosciences LLC
Voyager Therapeutics Inc
VTBIO Co Ltd
Vybion Inc
Vyripharm Biopharmaceuticals
Whan In Pharm Co Ltd
Wren Therapeutics Ltd
Xigen SA
Xonovo Inc
Yasham P2D Lifesciences Pvt Ltd
Yuhan Corp
Yuma Therapeutics Corp
Yumanity Therapeutics Inc
Zensun (Shanghai) Sci & Tech Co Ltd
Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co Ltd
Zhittya Genesis Medicine Inc
ZZ Biotech LLC